Pine Valley Investments’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,893
Closed -$427K 574
2025
Q2
$427K Sell
4,893
-83
-2% -$6.51K 0.02% 366
2025
Q1
$340K Sell
4,976
-165
-3% -$13.5K 0.02% 394
2024
Q4
$400K Sell
5,141
-538
-9% -$39.8K 0.02% 371
2024
Q3
$381K Buy
5,679
+2,111
+59% +$173K 0.02% 367
2024
Q2
$405K Buy
3,568
+1,430
+67% +$181K 0.03% 333
2024
Q1
$297K Sell
2,138
-41
-2% -$5.15K 0.02% 397
2023
Q4
$270K Buy
+2,179
New +$223K 0.02% 403

Other funds holding DXCM

Pine Valley Investments's DXCM Position: Q3 2025 in Review

Pine Valley Investments sold out of DexCom (DXCM) in Q3 2025, closing a stake of 4,893 shares — an estimated $427K sold.

Pine Valley Investments first reported a position in DXCM in Q4 2023 and held it in 7 quarters. The position peaked at $427K in Q2 2025. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Pine Valley Investments reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Pine Valley Investments sold 4,893 DexCom shares in Q3 2025, an estimated $427K.
  • Pine Valley Investments first reported a position in DexCom in Q4 2023 and held it in 7 quarters.
  • Pine Valley Investments's DexCom position peaked at $427K in Q2 2025.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Pine Valley Investments's 13F filing for Q3 2025, filed 17 Feb 2026.